The California Institute for Regenerative Medicine has approved the RAPID funding programme, setting aside $100m over two years.The post CIRM...
Telix Pharmaceuticals has dosed the first patient in its Phase III registration study of TLX591-Px aimed at prostate cancer imaging...
Ascletis Pharma has announced positive topline results from its Phase III open-label trial assessing the long-term safety of denifanstat in...
Repertoire Immune Medicines has collaborated with Eli Lilly for the development of tolerising therapies to treat several autoimmune diseases.The post...
Ardelyx has dosed the first patient in the ACCEL Phase III clinical trial evaluating Ibsrela (tenapanor) to treat CIC in...
RevBio has received the FDA investigational device exemption (IDE) approval to conduct a clinical trial of its cranial flap bone...
The FDA has granted breakthrough therapy designation to Biogen’s litifilimab for CLE, a chronic autoimmune skin condition.The post FDA grants...
QT Imaging Holdings has announced a new collaboration with Olea Medical to advance cloud-based breast imaging analytics.The post QT Imaging...
Arrowhead Pharmaceuticals has dosed the first participants in its Phase I/IIa clinical trial of ARO-DIMER-PA, an investigational dual functional RNAi...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.